Abstract:BACKGROUND:A great quantity of cell loss in early stage following stem cell transplantation can significantly affect transplantation effect.Presently,it is confirmed that overexpression of AKT1 gene significantly inhibit cell apoptosis.OBJECTIVE:To explore whether AKT1 gene overexpression can block stem cell apoptosis under hypoxic condition following pig autologous bone marrow mesenchymal stem cell (BMSC) transplantation,and the effect of repairing damaged myocardium.DESIGN,TIME AND SETTING:The randomized controlled animal study was performed at the Soochow University from August 2005 to February 2007.MATERIALS:A total of 24 healthy male Meishan pigs were supplied by the Animal Experimental Center of Soochow University.METHODS:The CDS (regulation domin of AKT1) AKT1-cDNA fragment was amplified.Lentivector Packaging Kit was used to transfect BMSCs after synthesized with pCDH1-AKT1 shuttling plasmid.Following BrdU labeling,models of myocardial infarction were constructed by occluding the distal left anterior descending coronary artery in pigs with gelatin sponge.4 weeks later,pigs were randomly divided into four groups:the model control group,the DMEM group,the BMSCs group,and the AKT-transfected group.In model control group,there was no other injection after occluding the left anterior descending coronary artery.In the DMEM group,5 mL DMEM was injected into the coronary artery.5 mL BMSCs (1×107 cells) were infused into the coronary artery in the BMSCs group.5 mL BMSCs transfected with the AKT1 gene were injected in the AKT-transfected group MAIN OUTCOME MEASURES:Western blot analysis and real time RT-PCR were used to test the plasmid.The cardiac function was evaluated by magnetic resonance image.Histological characteristics of the myocardium were observed using immunohistochemistry.Serum vascular endothelial growth factor and transforming growth factor β1 levels were determined by ELISA.RESULTS:AKT1-cDNA was cloned into pCDH1-MCS1-EF1-copGFP and the sequence was confirmed in comparison with the published one.AKT mRNA expression could be detected distinctly 24 and 48 hours after transfecting cells.The expression of AKT1 intensity in MSCs remained strong 2 weeks later with detected by real time RT-PCR and Western blot analysis.AKT1-mRNA transcriptional levels were 120 times of primary cells.Before the cell implantation,the left ventricular end-diastolic dimension increased and the stroke volume decreased in the myocardial infarction hearts.The cardiac function was significantly improved after cell implantation,and the implanted MSCs prevented the infarct region from thinning and expanding,improved contraction and increased perfusion in all groups relative to the control hearts.The left ventricular chamber size was smaller in the hearts with being transplanted cells than that in the control hearts.Moreover,the improvement was even markedly greater in AKT-transfected group (P < 0.05).Hematoxylin-eosin staining results showed that fibering was significant in the model control group and DMEM group.Island-like myocardium was observed in the infarct zone of the BMSCs group and AKT-transfected group,and plenty of small vessels-shape structure was detected in the AKT-transfected group.Immunohistochemistry demonstrated that Von Willebrand Factor (vWF) and Cx-43 expression was determined in the myocardium in the BMSCs group and AKT-transfected group,and the proportion of BrdU and Cx-43-positive cells to BrdU-positive cells was significantly greater in the AKT-transfected group compared with the BMSCs group 4 weeks following transplantation (P < 0.05).Following cell transplantation,vascular endothelial growth factor levels were gradually increased,peaked at 1 week,gradually decreased,and reached a normal level at 4 weeks.Transforming growth factor β1 levels were gradually reduced,and significantly less than the model control group,DMEM group 4 weeks later (P < 0.05),and significantly lower than that pretransplantation (P < 0.05).CONCLUSION:Using lentiviral vector to construct with AKT1 gene could stably make BMSCs overexpress AKT1.The BMSCs engraftment in host myocardium might improve the left ventricle function by attenuating the contractile dysfunction and pathologic thinning in this model of left ventricular wall infarction.AKT1 overexpression can significantly improve cardiac function following infarction.

Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction

Partial Restoration of Left Ventricular Systolic Function by asPLB Gene Transfer Using Ultrasound-Mediated Microbubble Destruction

Raav-Mediated Angiogenin Gene Transfer Induces Angiogenesis and Modifies Left Ventricular Remodeling in Rats with Myocardial Infarction

ANGPTL8 Reverses Established Adriamycin Cardiomyopathy by Stimulating Adult Cardiac Progenitor Cells.

Adenoviral VEGF-DΔN ΔC gene therapy for myocardial ischemia

Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model

Treatment of chronical myocardial ischemia by adenovirus-mediated hepatocyte growth factor gene transfer in minipigs

Gene Therapy with Hepatocyte Growth Factor Improves Left Ventricular Systolic Function After Myocardial Infarction: A Systematic Review and Meta-analysis of Pig Models

Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction

PLURIPOTENT STEM CELL-DERIVED CARDIOVASCULAR PROGENITORS DIFFFERENTIATED ON LAMININ 221 REGENERATE AND IMPROVE FUNCTION OF INFARCTED SWINE HEARTS

Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction

Graft of cardiac progenitors in a pig model of right ventricular failure triggers myocardial epimorphosis, regeneration and protection of function

HGF Percutaneous Endocardial Injection Induces Cardiomyocyte Proliferation and Rescues Cardiac Function in Pigs

Expression of Integrin-Linked Kinase Improves Cardiac Function in a Swine Model of Myocardial Infarction

Improved Cardiac Function in Postischemic Rats Using an Optimized Cardiac Reprogramming Cocktail Delivered in a Single Novel Adeno-Associated Virus

Improvement of Heart Function in Postinfarct Heart Failure Swine Models after Hepatocyte Growth Factor Gene Transfer: Comparison of Low-, Medium- and High-Dose Groups

Human iPSC-derived Committed Cardiac Progenitors Generate Cardiac Tissue Grafts in a Swine Ischemic Cardiomyopathy Model without Triggering Ventricular Arrhythmias

MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs

Transplantation of autologous bone marrow mesenchymal stem cells modified with AKT1 for treating pig ischemic cardiomyopathy

Abstract 11471: Engineered Bacterial Sodium Channel Gene Therapy Prevents Contractile Deficit and Reduces Ventricular Arrhythmias in a Non-Human Primate Model of Myocardial Infarction

Gene Therapy with the N-Terminus of Junctophilin-2 Improves Heart Failure in Mice